Streetbeat News

Revenues

RYTM

Analysts have provided diverse ratings for Rhythm Pharmaceuticals (NASDAQ:RYTM) over the past three months, with a majority being bullish. The average 12-month price target has increased by 9.82% to $60.4. The company has shown significant revenue growth but faces challenges with ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:01 pm

BNTX

Analysts have provided mixed ratings for BioNTech (NASDAQ:BNTX), with a majority being bullish. The average 12-month price target has increased to $121.33, with a high of $150.00 and a low of $85.00. Despite positive analyst sentiment, BioNTech faces financial challenges, including a decline in revenue and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:00 pm

CRL

In the past three months, 12 analysts have provided ratings for Charles River (NYSE:CRL), with a mix of bullish and bearish sentiments. The average 12-month price target has decreased by 14.54% to $211.08. Analysts have lowered their ratings and price targets, reflecting a cautious outlook. Despite challenges in revenue growth, Charles River shows strong profitability and financial health with high net margins, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:00 pm

PAYO

In the past three months, 7 analysts have rated Payoneer Global (NASDAQ:PAYO), with most being bullish. The average 12-month price target increased by 12.61% to $8.93. Analysts have raised their ratings and price targets, reflecting positive sentiment. Despite positive revenue growth, Payoneer faces challenges with net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:00 pm

NAPA

Duckhorn Portfolio reported its Q4 2024 financial results, with adjusted EPS of $0.14, surpassing the estimate of $0.10. Sales also exceeded expectations, reaching $107.395 million compared to the estimated $106.547 million.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:53 am

BABA

IVW

NVDA

XLK

Nvidia's GPU sales in China are at risk as the country pushes for domestic AI chips in response to US semiconductor sanctions. This could impact Nvidia's revenue from its H20 GPUs, a significant market for the company. Despite this, analysts remain optimistic about Nvidia's stock potential.

Portfolio Pulse from Anusuya Lahiri

October 07, 2024 | 11:52 am

SPY

USO

U.S. markets closed higher with the Dow reaching a record high, driven by a strong jobs report. Most S&P 500 sectors gained, while real estate and utilities fell. Crude oil prices rose by 2.5%. Asian markets showed mixed results, and European markets were mostly stable. U.S. futures indicated a decline.

Portfolio Pulse from Akanksha Bakshi

October 07, 2024 | 10:56 am

DRCR

SGN

Signing Day Sports (NYSE:SGN) is advancing its acquisition of Swifty Global (OTC:DRCR), focusing on growth and new revenue streams. The companies are working on a strategic roadmap to enhance shareholder value, improve operational efficiency, and explore global expansion. Swifty is providing a $150,000 promissory note to support the acquisition.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:32 am

MULN

Mullen Automotive Inc. (NASDAQ: MULN) forecasts $75 million in revenue over the next six months while cutting spending by $5.5 million through job reductions and program eliminations. The company aims to streamline operations and focus on commercial revenue growth.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:05 am

AMZN

APOG

NAPA

NFLX

TSLA

U.S. stocks rose on Friday, with the Dow Jones gaining over 300 points due to positive jobs data. Tesla, Amazon, and Netflix shares increased, while Apogee Enterprises surged 23% after strong earnings. The Fear & Greed Index remained in the 'Greed' zone, indicating positive market sentiment.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 7:46 am